MANAGEMENT OF FIBROMYALGIA: A COMPREHENSIVE REVIEW OF ESTABLISHED AND EMERGING THERAPEUTIC STRATEGIES AND PATHOPHYSIOLOGICAL MECHANISMS
DOI:
https://doi.org/10.31435/ijitss.4(48).2025.4421Keywords:
Fibromyalgia, Central Sensitization, Neuroinflammation, Chronic Pain, FatigueAbstract
Our review article summarizes current knowledge on the clinical features, underlying mechanisms, and therapeutic strategies for fibromyalgia. Recent evidence identifies fibromyalgia as a complex neuroimmune and neuroplastic disorder driven primarily by central sensitization, with additional contributions from peripheral nociceptor dysfunction, low-grade inflammation, neuroendocrine alterations, and psychosocial factors. These mechanisms explain the heterogeneous symptom profile, including widespread pain, fatigue, sensory hypersensitivity, cognitive impairment, and mood disturbances, suggesting the existence of distinct phenotypic subgroups. Current pharmacological treatments, such as tricyclic antidepressants, SNRIs, gabapentinoids, and sublingual cyclobenzaprine, offer moderate and variable benefits, while emerging agents targeting novel pathways remain under investigation. Non-pharmacological interventions, including structured exercise, cognitive-behavioral therapy, and selected complementary techniques, demonstrate comparable effectiveness, particularly within multidisciplinary care.
Overall, the literature highlights the need for personalized, holistic management and further biomarker-driven studies to advance precision-medicine approaches in fibromyalgia.
References
Iannuccelli, C., Favretti, M., Dolcini, G., Di Carlo, M., Pellegrino, G., Bazzichi, L., Atzeni, F., Lucini, D., Varassi, G., Leoni, M. L. G., Fornasari, D. M. M., Conti, F., Salaffi, F., Puttini, P. S., & Di Franco, M. (2025). Fibromyalgia: one year in review 2025. Clinical and Experimental Rheumatology, 43(6), 957–969. https://doi.org/10.55563/clinexprheumatol/buhd2z
Bair, M. J., & Krebs, E. E. (2020). Fibromyalgia. Annals of Internal Medicine, 172(5), ITC33–ITC48. https://doi.org/10.7326/aitc202003030
Inanici, F. F., & Yunus, M. B. (2004). History of fibromyalgia: Past to present. Current Pain and Headache Reports, 8(5), 369–378. https://doi.org/10.1007/s11916-996-0010-6
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., Fam, A. G., Farber, S. J., Fiechtner, J. J., Franklin, C. M., Gatter, R. A., Hamaty, D., Lessard, J., Lichtbroun, A. S., Masi, A. T., … Sheon, R. P. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis & Rheumatism, 33(2), 160–172.
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 62(5), 600–610.
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., & Winfield, J. B. (2011). Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. Arthritis Care & Research, 63(11), 1113–1122.
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., & Walitt, B. (2016). 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, 46(3), 319–329.
Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatology, 18(5), 728–733.
Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009). The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Research & Therapy, 11, R120. https://doi.org/10.1186/ar2783
Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: Global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129–138.
Dommerholt, J. (2009). Differential diagnosis of fibromyalgia (Chapter 8, pp. 179 213). W L. Chaitow (Ed.), Fibromyalgia Syndrome: A practitioner’s guide to treatment (3rd ed.). Edinburgh, UK: Churchill Livingstone.
Goldenberg, D. L. (2009). Diagnosis and differential diagnosis of fibromyalgia. The American Journal of Medicine, 122(12), S14–S21. https://doi.org/10.1016/j.amjmed.2009.09.007
Borg-Stein, J., & Simons, D. G. (2002). Myofascial pain. Archives of Physical Medicine and Rehabilitation, 83(3 Suppl 1), S40–S47. https://doi.org/10.1053/apmr.2002.32155
Fernández de las Peñas, C., Cuadrado, M. L., Arendt Nielsen, L., Simons, D. G., & Pareja, J. A. (2007). Myofascial trigger points and sensitization: An updated pain model for tension type headache. Cephalalgia, 27(5), 383–393. https://doi.org/10.1111/j.1468-2982.2007.01295.x
Chinn, S., Caldwell, W., & Gritsenko, K. (2016). Fibromyalgia pathogenesis and treatment Options update. Current Pain and Headache Reports, 20(4), 25. https://doi.org/10.1007/s11916-016-0556-x
Siracusa, R., Di Paola, R., Cuzzocrea, S., & Impellizzeri, D. (2021). Fibromyalgia: Pathogenesis, mechanisms, diagnosis and treatment options update. International Journal of Molecular Sciences, 22(8), 3891. https://doi.org/10.3390/ijms22083891
Benlidayi, I. C. (2019). Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatology International, 39(5), 781–791. https://doi.org/10.1007/s00296-019-04251-6
Badaeva, A., Danilov, A., Kosareva, A., Lepshina, M., Novikov, V., Vorobyeva, Y., & Danilov, A. (2024). Neuronutritional Approach to Fibromyalgia Management: A Narrative review. Pain and Therapy, 13(5), 1047–1061. https://doi.org/10.1007/s40122-024-00641-2
Tonix Pharmaceuticals. (2025, August 16). Tonix Pharmaceuticals announces FDA approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia. Tonix Pharmaceuticals. https://www.pharmafocusamerica.com/pharma-exclusives/press-releases/tonix-pharmaceuticals-announces-fda-approval-of-tonmya
Lederman, S., Arnold, L. M., Engels, J. M., Kelley, M., Vaughn, B., Sullivan, G. M., Ledford, C., & Tonix Fibromyalgia Study Group. (2025). Pain relief by targeting nonrestorative sleep in fibromyalgia: A Phase 3 randomized trial of bedtime sublingual cyclobenzaprine. Pain Medicine. Advance online publication. https://doi.org/10.1093/pm/pnaf089
Malik, A., Brown, Z., Ryder, A., Balayan, V., Jameson, L., Vu, P., Al-Jumah, R., & Hasoon, J. (2025b). Serotonin and Norepinephrine reuptake Inhibitors (SNRIs) for treatment of fibromyalgia: A Comprehensive Clinical review. Psychopharmacology Bulletin, 55(2), 24–40. https://doi.org/10.64719/pb.4519
Welsch, P., Üçeyler, N., Klose, P., Walitt, B., & Häuser, W. (2018b). Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database of Systematic Reviews, 2020(7), CD010292. https://doi.org/10.1002/14651858.cd010292.pub2
Albunayyan, R. F. (2022). A meta-analysis of the effect of selective serotonin reuptake inhibitors on pain in fibromyalgia. Journal of Pharmaceutical Research International, 54–65. https://doi.org/10.9734/jpri/2022/v34i40b36267
Calandre, E. P., Rico-Villademoros, F., & Slim, M. (2015). An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opinion on Pharmacotherapy, 16(9), 1347–1368. https://doi.org/10.1517/14656566.2015.1047343
Kia, S., & Choy, E. (2017). Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology. Biomedicines, 5(2), 20. https://doi.org/10.3390/biomedicines5020020
Hauser, W., Petzke, F., Uceyler, N., & Sommer, C. (2010). Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Lara D. Veeken, 50(3), 532–543. https://doi.org/10.1093/rheumatology/keq354
De Farias, Á. D., Eberle, L., Amador, T. A., & Da Silva Dal Pizzol, T. (2020). Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews. Advances in Rheumatology, 60(1), 35. https://doi.org/10.1186/s42358-020-00137-5
Alberti, F. F., Becker, M. W., Blatt, C. R., Ziegelmann, P. K., Da Silva Dal Pizzol, T., & Pilger, D. (2022). Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis. Clinical Rheumatology, 41(7), 1965–1978. https://doi.org/10.1007/s10067-022-06129-8
Tort, S., Urrútia, G., Nishishinya, M. B., & Walitt, B. (2012). Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Cochrane Database of Systematic Reviews, 2012(4), CD009807. https://doi.org/10.1002/14651858.cd009807
Welsch, P., Bernardy, K., Derry, S., Moore, R. A., & Häuser, W. (2018). Mirtazapine for fibromyalgia in adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012708.pub2
Ottman, A. A., Warner, C. B., & Brown, J. N. (2018). The role of mirtazapine in patients with fibromyalgia: a systematic review. Rheumatology International, 38(12), 2217–2224. https://doi.org/10.1007/s00296-018-4068-3
Miki, K., Murakami, M., Oka, H., Onozawa, K., Yoshida, S., & Osada, K. (2016). Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan. Pain, 157(9), 2089–2096. https://doi.org/10.1097/j.pain.0000000000000622
Arnold, L. M., Hirsch, I., Sanders, P., Ellis, A., & Hughes, B. (2012). Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen‐week, randomized, double‐blind, placebo‐controlled, multicenter clinical trial. Arthritis & Rheumatism, 64(7), 2387–2397. https://doi.org/10.1002/art.34390
Konuk, N., Ortancil, O., Bostanci, B., Kiran, S., & Sapmaz, P. (2010). A Comparison of Reboxetine and Amitriptyline in the Treatment of Fibromyalgia Syndrome with Co-morbid Depressive Symptoms: An Open-label Preliminary Study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 20(1), 29–37. https://doi.org/10.1080/10177833.2010.11790631
Stahl, S. M. (2009). Mechanism of action of trazodone: A multifunctional drug. CNS Spectrums, 14(10), 536–546. https://doi.org/10.1017/S1092852900024020
Morillas-Arques, P., Rodriguez-Lopez, C. M., Molina-Barea, R., Rico-Villademoros, F., & Calandre, E. P. (2010). Trazodone for the treatment of fibromyalgia: an open-label, 12-week study. BMC Musculoskeletal Disorders, 11(1), 204. https://doi.org/10.1186/1471-2474-11-204
Calandre, E. P., Morillas-Arques, P., Molina-Barea, R., Rodriguez-Lopez, C. M., & Rico-Villademoros, F. (2011). Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskeletal Disorders, 12(1), 95. https://doi.org/10.1186/1471-2474-12-95
Arnold, L. M., Choy, E., Clauw, D. J., Oka, H., Whalen, E., Semel, D., Pauer, L., & Knapp, L. (2018). An evidence-based review of pregabalin for the treatment of fibromyalgia. Current Medical Research and Opinion, 34(8), 1397–1409. https://doi.org/10.1080/03007995.2018.1450743
Ejaz, K. F., Wani, R., Akbar, A., Khan, Q. U., Ishtiaq, H., Amir, M., Ali, A. I., & Khan, S. (2024). Pain management in fibromyalgia: Evaluating the roles of pregabalin, duloxetine, and Milnacipran. Cureus, 16(12), e76631. https://doi.org/10.7759/cureus.76631
Cooper, T. E., Derry, S., Wiffen, P. J., & Moore, R. A. (2017). Gabapentin for fibromyalgia pain in adults. Cochrane Database of Systematic Reviews, 2018(3), CD012188. https://doi.org/10.1002/14651858.cd012188.pub2
North, J. M., Hong, K. J., & Rauck, R. L. (2015). The Effect of a Novel form of Extended‐Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open‐Label Pilot Study. Pain Practice, 16(6), 720–729. https://doi.org/10.1111/papr.12319
Khan, I., & Kahwaji, C. I. (2023, August 28). Cyclobenzaprine. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513362/
Giorgi, V., Sarzi-Puttini, P., Pellegrino, G., Sirotti, S., Atzeni, F., Alciati, A., Torta, R., Varrassi, G., Fornasari, D., Coaccioli, S., & Bongiovanni, S. F. (2024). Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based Review. Current Pain and Headache Reports, 28(12), 1349–1363. https://doi.org/10.1007/s11916-024-01277-9
Bourke, S. L., Schlag, A. K., O’Sullivan, S. E., Nutt, D. J., & Finn, D. P. (2022). Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research. Pharmacology & Therapeutics, 240, 108216. https://doi.org/10.1016/j.pharmthera.2022.108216
Strand, N. H., Maloney, J., Kraus, M., Wie, C., Turkiewicz, M., Gomez, D. A., Adeleye, O., & Harbell, M. W. (2023). Cannabis for the Treatment of Fibromyalgia: A Systematic review. Biomedicines, 11(6), 1621. https://doi.org/10.3390/biomedicines11061621
Berger, A. A., Keefe, J., Winnick, A., Gilbert, E., Eskander, J. P., Yazdi, C., Kaye, A. D., Viswanath, O., & Urits, I. (2020). Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Practice & Research Clinical Anaesthesiology, 34(3), 617–631. https://doi.org/10.1016/j.bpa.2020.08.010
Hurtado, I., Robles, C., Peiró, S., García-Sempere, A., Llopis, F., Sánchez, F., Rodríguez-Bernal, C., & Sanfélix, G. (2024). Long versus short-term opioid therapy for fibromyalgia syndrome and risk of depression, sleep disorders and suicidal ideation: a population-based, propensity-weighted cohort study. RMD Open, 10(3), e004466. https://doi.org/10.1136/rmdopen-2024-004466
Maffei, M. E. (2020). Fibromyalgia: recent advances in diagnosis, classification, pharmacotherapy and alternative remedies. International Journal of Molecular Sciences, 21(21), 7877. https://doi.org/10.3390/ijms21217877
Trofimovitch, D., & Baumrucker, S. J. (2019). Pharmacology update: Low-Dose naltrexone as a possible nonopioid modality for some chronic, nonmalignant pain syndromes. American Journal of Hospice and Palliative Medicine®, 36(10), 907–912. https://doi.org/10.1177/1049909119838974
Jimenez, X. F., Sundararajan, T., & Covington, E. C. (2017). A Systematic review of atypical antipsychotics in Chronic Pain Management. Clinical Journal of Pain, 34(6), 585–591. https://doi.org/10.1097/ajp.0000000000000567
Walitt, B., Klose, P., Üçeyler, N., Phillips, T., & Häuser, W. (2016). Antipsychotics for fibromyalgia in adults. Cochrane Database of Systematic Reviews, 2016(9), CD011804. https://doi.org/10.1002/14651858.cd011804.pub2
McIntyre, A., Kouassi, E., & Paisley, D. (2013). 2737 – A Double-Blind, randomized, Placebo-Controlled study evaluating the efficacy and safety of quetiapine XR for treatment of major depression and fibromyalgia. European Psychiatry, 28(S1). https://doi.org/10.1016/s0924-9338(13)77337-1
Littlejohn, G., & Guymer, E. (2017). Modulation of NMDA receptor activity in fibromyalgia. Biomedicines, 5(2), 15. https://doi.org/10.3390/biomedicines5020015
Pastrak, M., Abd-Elsayed, A., Ma, F., Vrooman, B., & Visnjevac, O. (2021). Systematic review of the use of intravenous ketamine for fibromyalgia. Ochsner Journal, 21(4), 387–394. https://doi.org/10.31486/toj.21.0038
Staud, R. (2011). Sodium oxybate for the treatment of fibromyalgia. Expert Opinion on Pharmacotherapy, 12(11), 1789–1798. https://doi.org/10.1517/14656566.2011.589836
Spaeth, M., Bennett, R. M., Benson, B. A., Wang, Y. G., Lai, C., & Choy, E. H. (2012). Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. Annals of the Rheumatic Diseases, 71(6), 935–942. https://doi.org/10.1136/annrheumdis-2011-200418
Brown, M. A., & Guilleminault, C. (2011). A review of sodium oxybate and baclofen in the treatment of sleep disorders. Current Pharmaceutical Design, 17(15), 1430–1435. https://doi.org/10.2174/138161211796197098
Alfaro-Rodríguez, A., Reyes-Long, S., Roldan-Valadez, E., González-Torres, M., Bonilla-Jaime, H., Bandala, C., Avila-Luna, A., Bueno-Nava, A., Cabrera-Ruiz, E., Sanchez-Aparicio, P., Maciel, A. G., Dotor-Llerena, A. L., Cortés-Altamirano, J. L. (2024). Association of the Serotonin and Kynurenine Pathways as Possible Therapeutic Targets to Modulate Pain in Patients with Fibromyalgia. Pharmaceuticals, 17(9), 1205. https://doi.org/10.3390/ph17091205
Park, D., Jeong, H., Choi, S., Kang, J., Lee, J., & Lee, S. (2024). Ramosetron as an add-on therapy for refractory fibromyalgia: a randomized, double-blind, placebo-controlled trial. Lara D. Veeken, 63(9), 2372–2378. https://doi.org/10.1093/rheumatology/keae310
Schertzinger, M., Wesson-Sides, K., Parkitny, L., & Younger, J. (2017). Daily Fluctuations of Progesterone and Testosterone Are Associated With Fibromyalgia Pain Severity. Journal of Pain, 19(4), 410–417. https://doi.org/10.1016/j.jpain.2017.11.013
White, H. D., & Robinson, T. D. (2015). A novel use for testosterone to treat central sensitization of chronic pain in fibromyalgia patients. International Immunopharmacology, 27(2), 244–248. https://doi.org/10.1016/j.intimp.2015.05.020
White, H. D., Brown, L. A., Gyurik, R. J., Manganiello, P. D., Robinson, T. D., Hallock, L. S., Lewis, L. D., & Yeo, K. J. (2015). Treatment of pain in fibromyalgia patients with testosterone gel: Pharmacokinetics and clinical response. International Immunopharmacology, 27(2), 249–256. https://doi.org/10.1016/j.intimp.2015.05.016
Bidonde, J., Busch, A. J., Schachter, C. L., Overend, T. J., Kim, S. Y., Góes, S. M., Boden, C., & Foulds, H. J. (2017). Aerobic exercise training for adults with fibromyalgia. Cochrane Database of Systematic Reviews, 2017(6), CD012700. https://doi.org/10.1002/14651858.cd012700
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., Dincer, F., Leino-Arjas, P., Longley, K., McCarthy, G. M., Makri, S., Perrot, S., Sarzi-Puttini, P., Taylor, A., & Jones, G. T. (2016). EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases, 76(2), 318–328. https://doi.org/10.1136/annrheumdis-2016-209724
Busch, A. J., Webber, S. C., Richards, R. S., Bidonde, J., Schachter, C. L., Schafer, L. A., Danyliw, A., Sawant, A., Bello-Haas, V. D., Rader, T., & Overend, T. J. (2013). Resistance exercise training for fibromyalgia. Cochrane Database of Systematic Reviews, 2014(7), CD010884. https://doi.org/10.1002/14651858.cd010884
Bidonde, J., Busch, A. J., Webber, S. C., Schachter, C. L., Danyliw, A., Overend, T. J., Richards, R. S., & Rader, T. (2014). Aquatic exercise training for fibromyalgia. Cochrane Database of Systematic Reviews, 2014(10), CD011336. https://doi.org/10.1002/14651858.cd011336
Del Mar López-Rodríguez, M., Castro-Sánchez, A. M., Fernández-Martínez, M., Matarán-Peñarrocha, G. A., & Rodríguez-Ferrer, M. E. (2012). Comparación entre biodanza en medio acuático y stretching en la mejora de la calidad de vida y dolor en los pacientes con fibromialgia. Atención Primaria, 44(11), 641–649. https://doi.org/10.1016/j.aprim.2012.03.002
Antunes, M. D., & Marques, A. P. (2022). The role of physiotherapy in fibromyalgia: Current and future perspectives. Frontiers in Physiology, 13, 968292. https://doi.org/10.3389/fphys.2022.968292
Yuan, S. L. K., Matsutani, L. A., & Marques, A. P. (2014). Effectiveness of different styles of massage therapy in fibromyalgia: A systematic review and meta-analysis. Manual Therapy, 20(2), 257–264. https://doi.org/10.1016/j.math.2014.09.003
Castro-Sánchez, A. M., Aguilar-Ferrándiz, M. E., Matarán-Peñarrocha, G. A., Del Mar Sánchez-Joya, M., Arroyo-Morales, M., & Fernández-De-Las-Peñas, C. (2013). Short-term effects of a manual therapy protocol on pain, physical function, quality of sleep, depressive symptoms, and pressure sensitivity in women and men with fibromyalgia syndrome. Clinical Journal of Pain, 30(7), 589–597. https://doi.org/10.1097/ajp.0000000000000008
Sun, P., Fang, L., Zhang, J., Liu, Y., Wang, G., & Qi, R. (2021). Repetitive Transcranial Magnetic Stimulation for Patients with Fibromyalgia: A Systematic Review with Meta-Analysis. Pain Medicine, 23(3), 499–514. https://doi.org/10.1093/pm/pnab276
García, Á. M., Serrano-Muñoz, D., Bravo-Esteban, E., Lafuente, S. A., Avendaño-Coy, J., & Gómez-Soriano, J. (2018). Efectos analgésicos de la estimulación eléctrica nerviosa transcutánea en pacientes con fibromialgia: una revisión sistemática. Atención Primaria, 51(7), 406–415. https://doi.org/10.1016/j.aprim.2018.03.010
Moshfeghinia, R., Shekouh, D., Mostafavi, S., Hosseinzadeh, M., Bahadori, A. R., Abdollahifard, S., & Razmkon, A. (2023). The effects of transcranial direct-current stimulation (tDCS) on pain intensity of patients with fibromyalgia: a systematic review and meta-analysis. BMC Neurology, 23(1), 395. https://doi.org/10.1186/s12883-023-03445-7
Yeh, S. W., Hong, C. H., Shih, M. C., Tam, K. W., Huang, Y. H., & Kuan, Y. C. (2019). Low-level laser therapy for fibromyalgia: A systematic review and meta-analysis. Pain Physician, 22(3), 241–254. https://pubmed.ncbi.nlm.nih.gov/31151332/
Da Silva, M. M., Albertini, R., De Tarso Camillo De Carvalho, P., Leal-Junior, E. C. P., Bussadori, S. K., Vieira, S. S., Bocalini, D. S., De Oliveira, L. V. F., Grandinetti, V., Silva, J. A., & Serra, A. J. (2017). Randomized, blinded, controlled trial on effectiveness of photobiomodulation therapy and exercise training in the fibromyalgia treatment. Lasers in Medical Science, 33(2), 343–351. https://doi.org/10.1007/s10103-017-2388-2
White, P. F., Zafereo, J., Elvir-Lazo, O. L., & Hernandez, H. (2017). Treatment of drug-resistant fibromyalgia symptoms using high-intensity laser therapy: a case-based review. Rheumatology International, 38(3), 517–523. https://doi.org/10.1007/s00296-017-3856-5
Ablin, J. N., Häuser, W., & Buskila, D. (2013). Spa Treatment (Balneotherapy) for Fibromyalgia—A Qualitative-Narrative Review and a Historical Perspective. Evidence-based Complementary and Alternative Medicine, 2013, 1–5. https://doi.org/10.1155/2013/638050
Bettoni, L., Bonomi, F. G., Zani, V., Manisco, L., Indelicato, A., Lanteri, P., Banfi, G., & Lombardi, G. (2013). Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients. Clinical Rheumatology, 32(9), 1337–1345. https://doi.org/10.1007/s10067-013-2280-9
Rivera, J., Tercero, M. J., Salas, J. S., Gimeno, J. H., & Alejo, J. S. (2018). The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin. Rheumatology International, 38(12), 2243–2250. https://doi.org/10.1007/s00296-018-4176-0
Atzeni, F., Masala, I. F., Cirillo, M., Boccassini, L., Sorbara, S., & Alciati, A. (2020). Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system. Clinical and Experimental Rheumatology, 38(Suppl. 123(1)), 94–98. https://pubmed.ncbi.nlm.nih.gov/32116209/
Chen, X., You, J., Ma, H., Zhou, M., & Huang, C. (2023). Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis. BMJ Open, 13(1), e062322. https://doi.org/10.1136/bmjopen-2022-062322
Cao, C., Li, Q., Zhang, X., Varrassi, G., & Wang, H. (2023). Effectiveness of Hyperbaric oxygen for Fibromyalgia: A Meta-Analysis of Randomized Controlled Trials. Clinics and Practice, 13(3), 583–595. https://doi.org/10.3390/clinpract13030053
Han, D., Lu, Y., Huang, R., Yang, Z., Peng, G., Qiao, Y., Zhang, X., Wu, H., & Liu, H. (2023). Acupuncture for Fibromyalgia: A review based on Multidimensional evidence. The American Journal of Chinese Medicine, 51(02), 249–277. https://doi.org/10.1142/s0192415x23500143
Zheng, C., Zhou, T., Zheng, C., & Zhou, T. (2022). Effect of Acupuncture on pain, fatigue, sleep, Physical function, Stiffness, Well-Being, and Safety in Fibromyalgia: A Systematic Review and Meta-Analysis. Journal of Pain Research, Volume 15, 315–329. https://doi.org/10.2147/jpr.s351320
Valera-Calero, J. A., Fernández-De-Las-Peñas, C., Navarro-Santana, M. J., & Plaza-Manzano, G. (2022). Efficacy of Dry Needling and Acupuncture in Patients with Fibromyalgia: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 19(16), 9904. https://doi.org/10.3390/ijerph19169904
Zhang, X., Chen, H., Xu, W., Song, Y., Gu, Y., & Ni, G. (2019). Acupuncture therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials. Journal of Pain Research, Volume 12, 527–542. https://doi.org/10.2147/jpr.s186227
Jensen, K. B., Kosek, E., Wicksell, R., Kemani, M., Olsson, G., Merle, J. V., Kadetoff, D., & Ingvar, M. (2012). Cognitive Behavioral Therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Pain, 153(7), 1495–1503. https://doi.org/10.1016/j.pain.2012.04.010
Lazaridou, A., Kim, J., Cahalan, C. M., Loggia, M. L., Franceschelli, O., Berna, C., Schur, P., Napadow, V., & Edwards, R. R. (2016). Effects of Cognitive-Behavioral therapy (CBT) on brain connectivity supporting catastrophizing in fibromyalgia. Clinical Journal of Pain, 33(3), 215–221. https://doi.org/10.1097/ajp.0000000000000422
Lee, J., Lazaridou, A., Paschali, M., Loggia, M. L., Berry, M. P., Ellingsen, D., Isenburg, K., Anzolin, A., Grahl, A., Wasan, A. D., Napadow, V., & Edwards, R. R. (2023). A randomized controlled neuroimaging trial of cognitive behavioral therapy for fibromyalgia pain. Arthritis & Rheumatology, 76(1), 130–140. https://doi.org/10.1002/art.42672
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
